Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 5Unspecified Adult Solid Tumor, Protocol Specific 2Refractory Solid Tumors 2Solid Tumors Refractory to Standard Therapy 1Solid Tumor 1Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1Malignant Solid Tumour 1Central Nervous System Metastases 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1Advanced Cancer 1

Interventions

temsirolimus 1olaparib 1figitumumab 1etirinotecan pegol 1Vemurafenib 1Temozolomide 1Surveys and Questionnaires 1Sunitinib 1Referral and Consultation 1Gemcitabine 1Everolimus 1Dasatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Cancer × Sunitinib × Other solid neoplasm × Clear all
NCT00729833 2014-06-09

Study Of CP-751,871 In Combination With Sunitinib In Patients With Advanced Solid Tumors

Pfizer

Phase 1 Terminated
45 enrolled 18 charts
Other solid neoplasm

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡